An advertisement for the product HeadsUp, which we published on this website, should not have been published.
In the advertisement we implied that HeadsUp was effective in the treatment and prevention of a range of symptoms that indicated a representations about mental illness such as depression, cognitive and mood disturbances, as well as increased blood pressure, tachycardia and others.
A complaint about the advertisement was recently upheld by the Complaints Resolution Panel. We provided no evidence whatsoever to support the claims we made, and the Panel found that the claims were unlawful, misleading, unverified and breached the Therapeutic Goods Act and the Therapeutic Goods Adevertising Code. The Panel also was very concerned that the advertising ran counter to public health and safety in relation to the drinking of alcohol in Australia.
The panel therefore requested that we publish this retraction.
The full text of the Panel's determination can be found at: www.tgacrp.com.au/complaints - reference 2015/03/002